替格瑞洛抵抗继发亚急性支架内血栓形成——神话还是现实！！ - Suppr

Suppr

超能文献

Sub-acute stent thrombosis secondary to ticagrelor resistance-Myth or reality!!

作者信息

Jariwala Pankaj, Bhatia Hemanshu, Kumar Edla Arjun Padma

机构信息

Department of Cardiology, Maxcure-Mediciti Hospitals, Opposite Secretariat, 500063, Hyderabad, Telangana, India.

出版信息

Indian Heart J. 2017 Nov-Dec;69(6):804-806. doi: 10.1016/j.ihj.2017.10.012. Epub 2017 Oct 26.

DOI:10.1016/j.ihj.2017.10.012

PMID:29174265

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5717319/

Abstract

摘要

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c05/5717319/801a06cbc78c/gr1.jpg

相似文献

Sub-acute stent thrombosis secondary to ticagrelor resistance-Myth or reality!!替格瑞洛抵抗继发亚急性支架内血栓形成——神话还是现实！！

Indian Heart J. 2017 Nov-Dec;69(6):804-806. doi: 10.1016/j.ihj.2017.10.012. Epub 2017 Oct 26.

Ticagrelor: the silence of the platelets.替格瑞洛：血小板的“沉默”。

Expert Opin Pharmacother. 2013 Feb;14(2):151-3. doi: 10.1517/14656566.2013.758252. Epub 2013 Jan 8.

First report of stent thrombosis after a switch therapy resulting from ticagrelor-related dyspnea.替格瑞洛相关呼吸困难导致换药治疗后发生支架内血栓形成的首例报告

Int J Cardiol. 2014 Oct 20;176(3):e127-8. doi: 10.1016/j.ijcard.2014.07.216. Epub 2014 Aug 5.

Bleeding risk and incidence in real world percutaneous coronary intervention patients with ticagrelor.

Heart Lung Circ. 2015 Apr;24(4):404-6. doi: 10.1016/j.hlc.2014.10.006. Epub 2014 Oct 30.

Antiplatelet effect of ticagrelor compared to tirofiban in non-ST-segment elevation ACS patients undergoing PCI. The result of the TE-CLOT trial.替格瑞洛与替罗非班在接受经皮冠状动脉介入治疗的非ST段抬高型急性冠状动脉综合征患者中的抗血小板作用。TE-CLOT试验结果。

Thromb Haemost. 2016 Jan;115(1):213-21. doi: 10.1160/TH15-02-0180. Epub 2015 Nov 19.

Int J Cardiol. 2015;187:517-8. doi: 10.1016/j.ijcard.2015.03.417. Epub 2015 Mar 31.

Impact of glycoprotein IIb/IIIa inhibitors on the efficacy and safety of ticagrelor compared with clopidogrel in patients with acute coronary syndromes: Analysis from the Platelet Inhibition and Patient Outcomes (PLATO) Trial.糖蛋白IIb/IIIa抑制剂对替格瑞洛与氯吡格雷相比在急性冠脉综合征患者中的疗效和安全性的影响：来自血小板抑制和患者预后（PLATO）试验的分析

Am Heart J. 2016 Jul;177:1-8. doi: 10.1016/j.ahj.2016.03.015. Epub 2016 Apr 13.

Prasugrel versus ticagrelor in acute coronary syndrome: a randomized comparison.普拉格雷与替格瑞洛用于急性冠状动脉综合征的随机对照比较

Int J Cardiol. 2013 Dec 10;170(2):e21-2. doi: 10.1016/j.ijcard.2013.10.043. Epub 2013 Oct 14.

Ticagrelor: a review of its use in adults with acute coronary syndromes.替格瑞洛：用于成人急性冠脉综合征的综述

Am J Cardiovasc Drugs. 2015 Feb;15(1):51-68. doi: 10.1007/s40256-015-0108-5.

Switching from ticagrelor to prasugrel: a warning.

Int J Cardiol. 2014 Oct 20;176(3):1089-90. doi: 10.1016/j.ijcard.2014.07.123. Epub 2014 Aug 1.

引用本文的文献

Resistance on the Latest Oral and Intravenous P2Y12 ADP Receptor Blockers in Patients with Acute Coronary Syndromes: Fact or Myth?急性冠状动脉综合征患者对最新口服和静脉用P2Y12 ADP受体阻滞剂的耐药性：事实还是误解？

J Clin Med. 2022 Dec 4;11(23):7211. doi: 10.3390/jcm11237211.

Double Whammy: Subacute Stent Thrombosis While Being Adherent to Dual Antiplatelet Therapy Including Ticagrelor, Followed by Multiple Coronary Artery Aneurysms in a COVID-19 Patient.双重打击：一名新冠病毒肺炎患者在坚持包括替格瑞洛在内的双联抗血小板治疗时发生亚急性支架血栓形成，随后出现多个冠状动脉瘤

Cureus. 2022 Feb 4;14(2):e21908. doi: 10.7759/cureus.21908. eCollection 2022 Feb.

Viscoelastic Hemostatic Assays and Platelet Function Testing in Patients with Atherosclerotic Vascular Diseases.动脉粥样硬化性血管疾病患者的粘弹性止血测定和血小板功能检测

Diagnostics (Basel). 2021 Jan 19;11(1):143. doi: 10.3390/diagnostics11010143.

One-Month Outcomes of Cases Receiving Ticagrelor after Percutaneous Coronary Intervention; a Case Series.经皮冠状动脉介入治疗后接受替格瑞洛治疗患者的1个月结局；病例系列

Arch Acad Emerg Med. 2020 Mar 30;8(1):e42. eCollection 2020.

本文引用的文献

Stent Thrombosis Patients with Hyporesponsiveness to Clopidogrel, Prasugrel, and Ticagrelor: A Case Series Using Short Thromboelastography.对氯吡格雷、普拉格雷和替格瑞洛低反应性的支架内血栓形成患者：一项使用短程血栓弹力图的病例系列研究

Case Rep Med. 2016;2016:2096181. doi: 10.1155/2016/2096181. Epub 2016 Oct 9.

Oral antiplatelet therapy and platelet inhibition: An experience from a tertiary care center.口服抗血小板治疗与血小板抑制：来自一家三级医疗中心的经验

Indian Heart J. 2016 Sep-Oct;68(5):624-631. doi: 10.1016/j.ihj.2015.12.022. Epub 2016 Jan 14.

Stent thrombosis in a patient with high on-treatment platelet reactivity despite ticagrelor treatment.尽管使用替格瑞洛治疗，但血小板高反应性患者仍发生支架内血栓形成。

Eur Heart J Acute Cardiovasc Care. 2015 Feb;4(1):85-7. doi: 10.1177/2048872614534563. Epub 2014 May 22.

Comparison of prasugrel and ticagrelor loading doses in ST-segment elevation myocardial infarction patients: RAPID (Rapid Activity of Platelet Inhibitor Drugs) primary PCI study.普拉格雷和替格瑞洛负荷剂量在 ST 段抬高型心肌梗死患者中的比较：RAPID（血小板抑制剂药物快速激活）直接经皮冠状动脉介入治疗研究。

J Am Coll Cardiol. 2013 Apr 16;61(15):1601-6. doi: 10.1016/j.jacc.2013.01.024. Epub 2013 Mar 22.

Incidence and predictors of coronary stent thrombosis: evidence from an international collaborative meta-analysis including 30 studies, 221,066 patients, and 4276 thromboses.冠状动脉支架血栓形成的发生率和预测因素：来自包括 30 项研究、221066 名患者和 4276 例血栓形成的国际合作荟萃分析的证据。

Int J Cardiol. 2013 Jul 31;167(2):575-84. doi: 10.1016/j.ijcard.2012.01.080. Epub 2012 Feb 22.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验